tiprankstipranks
Trending News
More News >
Dynavax Technologies Corp. (DVAX)
NASDAQ:DVAX

Dynavax (DVAX) Stock Statistics & Valuation Metrics

Compare
2,425 Followers

Total Valuation

Dynavax has a market cap or net worth of $1.23B. The enterprise value is $1.40B.
Market Cap$1.23B
Enterprise Value$1.40B

Share Statistics

Dynavax has 120,080,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding120,080,650
Owned by Insiders0.51%
Owned by Institutions38.66%

Financial Efficiency

Dynavax’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is -0.40%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)-0.40%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee684.56K
Profits Per Employee67.43K
Employee Count405
Asset Turnover0.28
Inventory Turnover0.71

Valuation Ratios

The current PE Ratio of Dynavax is 60.81. Dynavax’s PEG ratio is 0.02.
PE Ratio60.81
PS Ratio0.00
PB Ratio2.31
Price to Fair Value2.78
Price to FCF24.20
Price to Operating Cash Flow21.44
PEG Ratio0.02

Income Statement

In the last 12 months, Dynavax had revenue of 277.25M and earned 27.31M in profits. Earnings per share was 0.21.
Revenue277.25M
Gross Profit227.80M
Operating Income-4.12M
Pretax Income30.86M
Net Income27.31M
EBITDA45.70M
Earnings Per Share (EPS)0.21

Cash Flow

In the last 12 months, operating cash flow was 63.55M and capital expenditures -9.53M, giving a free cash flow of 54.02M billion.
Operating Cash Flow63.55M
Free Cash Flow54.02M
Free Cash Flow per Share0.45

Dividends & Yields

Dynavax pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.36
52-Week Price Change-9.44%
50-Day Moving Average10.56
200-Day Moving Average11.94
Relative Strength Index (RSI)50.72
Average Volume (3m)1.99M

Important Dates

Dynavax upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateMay 6, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date

Financial Position

Dynavax as a current ratio of 10.80, with Debt / Equity ratio of 44.41%
Current Ratio10.80
Quick Ratio9.91
Debt to Market Cap0.13
Net Debt to EBITDA3.47
Interest Coverage Ratio-0.61

Taxes

In the past 12 months, Dynavax has paid 3.55M in taxes.
Income Tax3.55M
Effective Tax Rate0.11

Enterprise Valuation

Dynavax EV to EBITDA ratio is 39.81, with an EV/FCF ratio of 30.24.
EV to Sales6.56
EV to EBITDA39.81
EV to Free Cash Flow30.24
EV to Operating Cash Flow27.35

Balance Sheet

Dynavax has $661.34M in cash and marketable securities with $286.03M in debt, giving a net cash position of -$375.31M billion.
Cash & Marketable Securities$661.34M
Total Debt$286.03M
Net Cash-$375.31M
Net Cash Per Share-$3.13
Tangible Book Value Per Share$4.57

Margins

Gross margin is 63.73%, with operating margin of -1.49%, and net profit margin of 9.85%.
Gross Margin63.73%
Operating Margin-1.49%
Pretax Margin11.13%
Net Profit Margin9.85%
EBITDA Margin16.48%
EBIT Margin13.58%

Analyst Forecast

The average price target for Dynavax is $22.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$22.00
Price Target Upside114.22% Upside
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast24.76%
EPS Growth Forecast-783.38%

Scores

Smart Score6
AI Score48
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis